Aktienkurs
188.30
Täglich Wechseln
-4.10 -2.13%
Monatlich
0.48%
Jährlich
-25.81%
Q1 Prognose
186.47




Ebitda Veränderung Datum
Demant DKK 2.76B 165M 2025-12
EDAP TMS EUR -4.92M 843K 2025-09
Essilor EUR 3.09B 356M 2024-12
Fresenius EUR 850M 22M 2025-09
Fresenius Medical Care EUR 1.07B 142.74M 2025-12
Genmab DKK 477M 101M 2025-09
Getinge SEK 3.47B 2.13B 2024-12
GN Store Nord DKK 627M 106M 2025-12
Lonza CHF 1.01B 54M 2025-12
Pandora DKK 4.79B 3.27B 2025-12
Philips EUR 738M 9M 2025-09
Smith & Nephew USD 796M 139M 2025-12
Trinity Biotech USD -9.6M 7.64M 2024-12